OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cannabis and Endocannabinoid Signaling in Epilepsy
István Katona
Handbook of experimental pharmacology (2015), pp. 285-316
Closed Access | Times Cited: 70
István Katona
Handbook of experimental pharmacology (2015), pp. 285-316
Closed Access | Times Cited: 70
Showing 1-25 of 70 citing articles:
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 133-150
Closed Access | Times Cited: 535
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 133-150
Closed Access | Times Cited: 535
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 623-639
Closed Access | Times Cited: 409
Vincenzo Di Marzo
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 623-639
Closed Access | Times Cited: 409
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 207
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 207
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
Daniel Friedman, Jacqueline A. French, Mauro Maccarrone
The Lancet Neurology (2019) Vol. 18, Iss. 5, pp. 504-512
Closed Access | Times Cited: 185
Daniel Friedman, Jacqueline A. French, Mauro Maccarrone
The Lancet Neurology (2019) Vol. 18, Iss. 5, pp. 504-512
Closed Access | Times Cited: 185
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 145
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 145
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
Sagnik Bhattacharyya, Robin Wilson, Elizabeth Appiah‐Kusi, et al.
JAMA Psychiatry (2018) Vol. 75, Iss. 11, pp. 1107-1107
Open Access | Times Cited: 130
Sagnik Bhattacharyya, Robin Wilson, Elizabeth Appiah‐Kusi, et al.
JAMA Psychiatry (2018) Vol. 75, Iss. 11, pp. 1107-1107
Open Access | Times Cited: 130
Lower circulating endocannabinoid levels in children with autism spectrum disorder
Adi Aran, Maya Eylon, Moria Harel, et al.
Molecular Autism (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 123
Adi Aran, Maya Eylon, Moria Harel, et al.
Molecular Autism (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 123
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels
Luciano Vilela, Isabel Vieira de Assis Lima, Érica B. Kunsch, et al.
Epilepsy & Behavior (2017) Vol. 75, pp. 29-35
Closed Access | Times Cited: 115
Luciano Vilela, Isabel Vieira de Assis Lima, Érica B. Kunsch, et al.
Epilepsy & Behavior (2017) Vol. 75, pp. 29-35
Closed Access | Times Cited: 115
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 89
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 89
Deconstructing the neurobiology of cannabis use disorder
Jacqueline‐Marie N. Ferland, Yasmin L. Hurd
Nature Neuroscience (2020) Vol. 23, Iss. 5, pp. 600-610
Open Access | Times Cited: 78
Jacqueline‐Marie N. Ferland, Yasmin L. Hurd
Nature Neuroscience (2020) Vol. 23, Iss. 5, pp. 600-610
Open Access | Times Cited: 78
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Cannabidiol and epilepsy: Rationale and therapeutic potential
Antonio Leo, Emilio Russo, Maurizio Elia
Pharmacological Research (2016) Vol. 107, pp. 85-92
Closed Access | Times Cited: 70
Antonio Leo, Emilio Russo, Maurizio Elia
Pharmacological Research (2016) Vol. 107, pp. 85-92
Closed Access | Times Cited: 70
Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
Anastasia Suraev, Nick Lintzeris, Jordyn Stuart, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 69
Anastasia Suraev, Nick Lintzeris, Jordyn Stuart, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 69
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use
Anastasia Suraev, Lisa M. Todd, Michael T. Bowen, et al.
Epilepsy & Behavior (2017) Vol. 70, pp. 334-340
Open Access | Times Cited: 66
Anastasia Suraev, Lisa M. Todd, Michael T. Bowen, et al.
Epilepsy & Behavior (2017) Vol. 70, pp. 334-340
Open Access | Times Cited: 66
<p>Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects</p>
Alessandra Morano, Martina Fanella, Mariarita Albini, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 381-396
Open Access | Times Cited: 66
Alessandra Morano, Martina Fanella, Mariarita Albini, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 381-396
Open Access | Times Cited: 66
Cannabinoid receptor type-1: breaking the dogmas
Arnau Busquets‐Garcia, Edgar Soria‐Gómez, Luigi Bellocchio, et al.
F1000Research (2016) Vol. 5, pp. 990-990
Open Access | Times Cited: 63
Arnau Busquets‐Garcia, Edgar Soria‐Gómez, Luigi Bellocchio, et al.
F1000Research (2016) Vol. 5, pp. 990-990
Open Access | Times Cited: 63
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
Aisling O’Neill, Robin Wilson, Grace Blest‐Hopley, et al.
Psychological Medicine (2020) Vol. 51, Iss. 4, pp. 596-606
Closed Access | Times Cited: 63
Aisling O’Neill, Robin Wilson, Grace Blest‐Hopley, et al.
Psychological Medicine (2020) Vol. 51, Iss. 4, pp. 596-606
Closed Access | Times Cited: 63
Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
Pierangelo Cifelli, Gabriele Ruffolo, Eleonora De Felice, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 723-723
Open Access | Times Cited: 52
Pierangelo Cifelli, Gabriele Ruffolo, Eleonora De Felice, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 723-723
Open Access | Times Cited: 52
Cannabinoids as hippocampal network administrators
Carl R. Lupica, Yuhan Hu, Orrin Devinsky, et al.
Neuropharmacology (2017) Vol. 124, pp. 25-37
Closed Access | Times Cited: 51
Carl R. Lupica, Yuhan Hu, Orrin Devinsky, et al.
Neuropharmacology (2017) Vol. 124, pp. 25-37
Closed Access | Times Cited: 51
Generation of Febrile Seizures and Subsequent Epileptogenesis
Bo Feng, Zhong Chen
Neuroscience Bulletin (2016) Vol. 32, Iss. 5, pp. 481-492
Open Access | Times Cited: 49
Bo Feng, Zhong Chen
Neuroscience Bulletin (2016) Vol. 32, Iss. 5, pp. 481-492
Open Access | Times Cited: 49
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice
Erica Zamberletti, Marina Gabaglio, Fabiana Piscitelli, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 7, pp. 894-907
Open Access | Times Cited: 46
Erica Zamberletti, Marina Gabaglio, Fabiana Piscitelli, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 7, pp. 894-907
Open Access | Times Cited: 46
Seizure-induced strengthening of a recurrent excitatory circuit in the dentate gyrus is proconvulsant
Kaoutsar Nasrallah, M. Agustina Frechou, Young J. Yoon, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 32
Open Access | Times Cited: 24
Kaoutsar Nasrallah, M. Agustina Frechou, Young J. Yoon, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 32
Open Access | Times Cited: 24
CB1 Receptor Signaling: Linking Neuroplasticity, Neuronal Types, and Mental Health Outcomes
Qianqian Gao, Muhammad Asim
Neurochemistry International (2025), pp. 105938-105938
Closed Access
Qianqian Gao, Muhammad Asim
Neurochemistry International (2025), pp. 105938-105938
Closed Access
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity
Roberto Colangeli, Massimo Pierucci, A Benigno, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 44
Roberto Colangeli, Massimo Pierucci, A Benigno, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 44
